|
|
| Supervisory Board |
 |
 |
 |
Prof. Dr. Dr. Rolf Krebs Chairman
Prof. Dr. Dr. Uwe Bicker Deputy-Chairman
Prof. Dr. Guenther Reiter
Dr. Ann Clare Kessler
Günther Frankenne
Heino von Prondzynski
|
|
 |
 |
|
 |
Prof. Dr. Dr. Rolf Krebs (Chairman), ex-Boehringer Ingelheim
Prof. Krebs was Chairman of the Board of Managing Directors at Boehringer Ingelheim headquartered in Ingelheim/Germany which he joined in 1989. Prior to that he was in various functions within the pharmaceutical division of Bayer AG, Leverkusen, followed by a position as Vice CEO with Bayer Italia S.p.A. in Milan. He served as President of EFPIA, the European pharma association, from 1996 – 1998 and is the current President of IFPMA, the world pharma association. Professor Krebs holds various posts in the advisory boards of major German companies.
|
|
 |
|
 |
Günther Frankenne
Günther Frankenne is an Economist who started his professional career at Sandoz AG in 1968. He served as CEO of Wander Pharma and as CEO of Sandoz AG. He was involved in the 3-year merger-process between Ciba-Geigy and Sandoz to form Novartis, where he held the position of Deputy Chairman and has been active until his retirement in 1999. Furthermore, he headed committees at the Bundesverband der Pharmazeutischen Industrie (BPI) and Verband forschender Arzneimittelhersteller (VFA). Currently Günther Frankenne is a Board member of “Forum Medizin Technik und Pharma” (initiated by the Ministry of Economic Affairs in Bavaria) and acts as consultant for Health Care companies. In his capacity he holds positions in various Supervisory Boards.
|
|
 |
|
 |
Heino von Prondzynski
Heino von Prondzynski is a well-known expert in the diagnostics industry and looks back at a distinguished career in several leading diagnostic companies. Until December 2005, he headed the Diagnostics Division at F.Hoffmann-La Roche AG, Basel. Before that he held senior positions in the Vaccine business at Chiron Corp. in Germany, Italy and US and in the Pharma, Self-medication and Diagnostic business at Bayer AG in Germany, Austria and Brazil. After retiring from his position as CEO of the Roche Diagnostics division, Heino von Prondzynski works as an independent consultant and holds further posts in the boards of BB MedTech AG, Schaffhausen, Switzerland, Koninklijke Philips Electronics N.V. (Royal Philips Electronics), Eindhoven, The Netherlands and Qiagen N.V., Venlo, The Netherlands.
|
|
top of the page
|